Startups

Biotech Allison DeAngelis

STAT Plus: One of biotech’s biggest financiers launches small-molecule startup, in spite of IRA’s looming shadow

Health tech Mohana Ravindranath

STAT Plus: In Silicon Valley, a venture capital firm gives health tech startups a crash course in getting paid

Biotech Allison DeAngelis

STAT Plus: Biotech startups are hungry for dollars. Here’s what one pharma executive was looking for at JPM

The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein

BIO’s messy transition, mRNA’s future, & Biogen’s next CEO

Health tech Ambar Castillo

STAT Plus: These 3 startups are trying to improve diversity in clinical trials, a challenge experts say will take more than just tech

Biotech Allison DeAngelis

STAT Plus: Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight

Biotech Kate Sheridan

STAT Plus: When biotech acquisitions spike, early-stage startups are prime targets, analysis shows

Biotech Kate Sheridan

STAT Plus: 3 biotech trends to watch in 2022

Biotech Kate Sheridan

STAT Plus: Biotech investor Eli Casdin on biotech’s bad December 

Biotech Kate Sheridan

STAT Plus: At biotech venture capital firms, collecting ‘consulting fees’ from startups has become widespread

Exclusive Kate Sheridan

STAT Plus: Flagship to launch a new startup focused on neurodegenerative conditions, including Parkinson’s

Biotech Maddie Bender

STAT Plus: 4 food allergy immunotherapy companies to watch

Biotech Damian Garde

STAT Plus: Moderna, making billions from its vaccine, bets on a genome-editing startup

Biotech Kate Sheridan

STAT Plus: In the ‘fail fast’ world of biotech, ‘offboarding’ is just as important as onboarding

Biotech Kate Sheridan

STAT Plus: In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching

Exclusive Kate Sheridan

STAT Plus: Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms

Biotech Kate Sheridan

STAT Plus: Startup Spotlight: Vigil Neuroscience hopes to eventually target the rare disease ALSP 

Biotech Kate Sheridan

STAT Plus: Startup Spotlight: Encoded eyes a gene therapy for Dravet syndrome

Biotech Kate Sheridan

STAT Plus: How much is a startup worth? For biotech companies, the answer is rarely public

Biotech Kate Sheridan

STAT Plus: 4 questions for neurology startups as venture investors pour millions into the field

Something Ventured Kate Sheridan

STAT Plus: Finch Therapeutics and three other startups got venture funding a year ago. Did it help them do what they said it would?

First Opinion Laurie Halloran

5 top blunders life science startups make on the road to clinical trials

First Opinion Swati Chaturvedi

Investing in a startup? Follow the data, not the herd

Business Andrew Joseph

Researchers take the plunge into industry — without leaving the ivory tower

Business Robert Weisman — Boston Globe

Startup Editas plans to test IPO market for biotechs

Business Andrew Joseph

Executives-for-hire help biotech startups get off the ground